Abstract
CHOP, a member of the C/EBP family of the transcriptional factor, showed a tumor suppressor activity by binding to TCF and inhibiting the Wnt signaling pathway. In this study, to determine whether genetic alterations of CHOP gene are involved in the development and/or progression of the gastric cancers, we have screened a set of 47 gastric adenoma and 81 sporadic gastric cancers for mutations and allelic loss. In mutation analysis, we found one and five somatic missense mutations, P41T, E69K, S79N, P80S, P80L and G36S, in gastric adenoma and cancer, respectively. All of the mutations were detected in transactivation domain of the CHOP gene. An allelic loss was found in 19 (38.8%) of forty-nine informative cases at one or both microsatellite markers, D12S305 and D12S1691. Clinically, five cancer cases with mutations were of intestinal-type gastric cancers and three mutations were found in the cases with surrounding lymph node metastasis. These data suggest that genetic alterations of the CHOP gene may play an important role in the development of sporadic gastric cancers.
Similar content being viewed by others
References
Ferlay, J. et al. GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon (France): IARC; 2010, Available from: http://globocan.iarc.fr
Jung, K. W. et al. Cancer statistics in Korea: incidence, mortality and survival in 2006–2007. J Korean Med Sci 25:1113–1121 (2010).
Katoh, M. WNT/PCP signaling pathway and human cancer. Oncol Rep 14:1583–1588 (2005).
Polakis, P. The many ways of Wnt in cancer. Curr Opin Genet Dev 17:45–51 (2007).
Lustig, B. & Behrens, J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 129:199–221 (2003).
Park, W. S. et al. Frequent somatic mutations of the β-catenin gene in intestinal-type gastric cancer. Cancer Res 59:4257–4260 (1999).
Ebert, M. P. et al. Increased β-catenin mRNA levels and mutational alterations of the APC and β-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 23:87–91 (2002).
Kim, C. J. et al. Inactivating mutations of the Siah-1 gene in gastric cancer. Oncogene 23:8591–8596 (2004).
Ramji, D. P. & Foka, P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365:561–575 (2002).
Ubeda, M. et al. Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element. Mol Cell Biol 16:1479–1489 (1996).
Talukder, A. H., Wang, R. A. & Kumar, R. Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells. Oncogene 21:4289–4300 (2002).
Tagawa, Y. et al. Induction of apoptosis by cigarette smoke via ROS-dependent endoplasmic reticulum stress and CCAAT/enhancer-binding protein-homologous protein (CHOP). Free Radic Biol Med 45:50–59 (2008).
Huang, S. M. et al. Phloroglucinol derivative MCPP induces cell apoptosis in human colon cancer. J Cell Biochem 112:643–652 (2011).
Sung, B., Ravindran, J., Prasad, S., Pandey, M. K. & Aggarwal, B. B. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL. J Biol Chem 285:35418–35427 (2010).
Yamazaki, T. et al. Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells. Life Sci 87:294–301 (2010).
Scott, D. W. & Loo, G. Curcumin-induced GADD153 gene up-regulation in human colon cancer cells. Carcinogenesis 25:2155–2164 (2004).
Prasad, S., Yadav, V. R., Ravindran, J. & Aggarwal, B. B. ROS and CHOP are critical for dibenzylideneacetone to sensitize tumor cells to TRAIL through induction of death receptors and downregulation of cell survival proteins. Cancer Res 71:538–549 (2011).
Horndasch, M. et al. The C/EBP homologous protein CHOP(GADD153) is an inhibitor of Wnt/TCF signals. Oncogene 25:3397–3407 (2006).
Yuasa, Y. Control of gut differentiation and intestinaltype gastric carcinogenesis. Nat Rev Cancer 3:592–600 (2003).
Song, J. H. et al. Genetic alterations of the Cdx2 gene in gastric cancer. APMIS 116:74–80 (2008).
Shtutman, M., Zhurinsky, J., Oren, M., Levina, E. & Ben-Ze’ev, A. PML is a target gene of β-catenin and plakoglobin, and coactivates β-catenin-mediated transcription. Cancer Res 62:5947–5954 (2002).
Tetsu, O. & McCormick, F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426 (1999).
Tiwary, R. et al. Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis. PLoS One 5:e11865 (2010)
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work
Rights and permissions
About this article
Cite this article
Song, J.H., Park, J.K., Yoon, J.W. et al. Genetic alterations of the CHOP gene in gastric cancers. Mol. Cell. Toxicol. 7, 1–6 (2011). https://doi.org/10.1007/s13273-011-0001-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13273-011-0001-5